SNDX:NASDAQ, Syndax Pharmaceuticals, Inc.

SNDX stock overview

Syndax Pharmaceuticals, Inc. (SNDX:NASDAQ) closed at $9.45 on November 13, 2026, down 0.94% on the day. The stock trades 63.1% below its 52-week high of $25.59 and 3.7% above its 52-week low of $9.11. Over the past year, it lost 43.1%. Syndax Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$9.45
Day change
-0.94%
Volume
3,179,507
Average volume
2,472,153
Market cap
850M+
52-week range
$9.11 – $25.59
50-day average
$15.50
200-day average
$19.78

Price action over the past year

In 252 trading sessions since November 13, 2025, SNDX closed higher on 113 days (45%). Its best day was November 24, 2025 (+13.30%) and its worst was November 4, 2026 (-26.87%). The stock moved 10% or more in a single session 5 times.

Recent signals

SNDX news

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications.

Similar stocks

Find more stocks like SNDX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.